| sIL-2R in liver disease patients | |
---|---|---|
(n = 71) | ||
r | p | |
Liver Function | Â | Â |
albumin | −0.496 | <0.001 |
pseudocholinesterase | −0.484 | <0.001 |
international normalized ratio | 0.349 | 0.003 |
bilirubin | 0.265 | 0.025 |
alkaline phosphatase | 0.248 | 0.037 |
Hepatic fibrosis | Â | Â |
hyaluronic acid | 0.383 | 0.003 |
procollagen-III-peptide | 0.514 | <0.001 |
Inflammation | Â | Â |
total monocytes | 0.366 | 0.002 |
CD14++CD16- monocytes | 0.332 | 0.006 |
CD14+CD16+ monocytes | 0.402 | 0.001 |
IL-2 | 0.310 | 0.010 |
IL-4 | 0.271 | 0.025 |
IL-6 | 0.476 | 0.000 |
IL-8 (CXCL8) | 0.308 | 0.011 |
IL-10 | 0.388 | 0.001 |
IFNγ | 0.297 | 0.014 |
G-CSF | 0.239 | 0.049 |
MIP1α (CCL3) | 0.359 | 0.002 |
MIP1β (CCL4) | 0.244 | 0.045 |
MIG (CXCL9) | 0.329 | 0.006 |
IP-10 (CXCL10) | 0.340 | 0.005 |
fractalkine (CX3CL1) | 0.398 | 0.001 |
Renal Function | Â | Â |
cystatin C | 0.603 | <0.001 |
creatinine | 0.301 | 0.011 |
urea | 0.266 | 0.026 |